FDA cites the company for GMP violations, including failing to establish specifications for identity, purity, strength, and composition for its components.
In a warning letter sent September 22 to Herbal Nitro Inc., FDA holds the company, and not its contract manufacturers, responsible for Good Manufacturing Practices (GMP) infractions related to the company’s products.
“As an own-label dietary supplement distributor that contracts with other manufacturers to manufacture dietary supplements that your firm releases for distribution under your firm’s name, FDA considers you to be a manufacturer of dietary supplements. As such, you have ultimate responsibility for the dietary supplements that you introduce or deliver for introduction into interstate commerce,” states FDA’s letter.
FDA’s letter cites the company for GMP violations, including failing to establish specifications for identity, purity, strength, and composition for its components and for failing to conduct tests to verify ingredient identity, as we as for insufficient recordkeeping of product distribution.
Nutritional Outlook thanks Harry Rice for the tip.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.